Skip to content
healthcare.dev

bupropion

NDC 65841-836, bupropion, tablet, extended release, from Zydus Lifesciences Limited.

Product NDC
65841-836
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201567
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65841-836 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE150 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
65841-836-0565841083605500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-05)
65841-836-066584108360630 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-06)
65841-836-10658410836101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-10)
65841-836-166584108361690 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-16)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/78d34aad-9d4f-48c4-91eb-536e31c6b6c9

Use it

Look up 65841-836 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65841-836 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65841-836. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.